Анотация: The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been associated with stroke prevention. This stroke prevention appears to occur apart from cholesterol lowering effects. A number of mechanisms have been postulated for this pre/style> ;

M.; Soto, S.>e-sub">яflow: hidden; } #info { color: #fff; position: absolute; top: 10px; width: 100%; text-align: center; z-index: 100; display:block; } #info a, .button { color: #f00; font-weight: bold; text-vention. The aim of our study was to investigate the effect of simvastatin on the c-fos gene activity and its relation to delayed neuronal death in CA1 region of hippocampus following transient forebrain ischemia in the adult rat hippocampus. A total of 1loadingImage" style="position:absolute; top:50%; left:50%;" src="TйшCa6\ЇTйаSйxJ™"­аSй„W
ИЂф@ Ѓфаtн®?§X

X
ђѓфU X
Ёѓф@`
8ЎҐ
®?§X

X
Иѓф`
X
ёѓфаѓфW
x‚фш‚фPѓфpѓфV
‚ф@`
Ќо®?§[

[
(„ф0„ф@р„фаtн®?§[

[
P„ф`
@`
®?§[
[
h„фx„ф[
@„фђ„ф@uffi8ЎҐ
®?§\

\
°„фuffi@и®?§\
\
И„фШ„фѓ\

р„ф`

`
@ш„ф8ЎҐ
®?§\

\
…ф`
@
[ 8Ќо®?§
\
@р„фаtн®?§\

\
`…ф`…фЂ\

x…ф
`
Ђ…ф\ \
H…ф€…ф \
8…фЁ…фѓ\

ё…фa

a
@\ 8ЎҐ
®?§\

\
и…фa

\
†ф\ ѓ\

†ф
b
†ф †ф„\
 ‡фp‰ф€Њф@\ @аtн®?§]

]
`†фV@8ЎҐ
®?§]

]
€†фb
]
x†ф †ф@(…фЌо®?§]

]
А†фb
@
®?§]

]
Ш†фи†ф ]
°†ф‡ф„]

Ђ‡ф@] Чу@c
`iй®?§]

]
@‡ф@c
аЌо®?§
]
]
X‡фh‡ф]
‡ф ‡ф…]

ђ‡фё…ф†ф ‡фЂ‡ф@PЉфИБф®?§^

^
А‡ф@аtн®?§^

^
и‡фи@8ЎҐ
®?§^

^
€фи^
€ф(€ф ^
Ш‡ф8€ф„^

P‰ф
e
@c @`iй®?§_

_
x€фe
@€€ф°|з®?§
_
@ €фаtн®?§_

_
ё€фd @V8ЎҐ
®?§_

_
а€фа€ф_
Р€фш€ф _
 €ф‰ф@d @хн®?§
_
_
‰ф(‰ф_
ђ€ф@‰ф^
H€фX€ф…^
`‰фр‹фd sн„`

а‹фp‰фЂ‰ф@ †ф@`iй®?§a

a
°‰фe
@€€ф`ун®?§
a
@
0Љф ун®?§
a


a
р‰фe
a
Ш‰фЉф@e
ЁВц®?§
a
a
Љф(Љф@e
+®?§a

a
PЉфf
a
@ЉфhЉф@LЫ!ёЋо®?§
a
a
xЉф€Љф@LЫ!аtн®?§a

a
°Љфи@g 8ЎҐ
®?§a

a
ШЉфШЉфa
ИЉфрЉф a
 Љф‹ф@‹фЏо®?§
a
a
‹ф ‹ф@(‹фаtн®?§7 male Wistar albino rats were used in this study. The animals were divided into three groups: 5 sham-operated animals; 6 ischemised rats without statin pre-treatment and 6 ischemised rats with statin pre-treatment. We used simvastatin at the dose of 20 mg/kg during 14 days prior to the ischemic attack. Fifteen min long transient forebrain ischemia was induced by the four-vessel occlusion. Two and a half h reperfusion was used for the c-Fos activity detection using immunostaining and 72 h reperfusion was used for the determination of neurons surviving using haematoxylin/eosin staining. The average neuronal density in the CA1 region of hippocampus in the sham-operated rats, in ischemised rats without pre-treatment and in ischemised rats with statin pre-treatment was 47.03 с 3.09/0,025 mm2, 9.05 с 2.46/0,025 mm2 and 16.45 с 2.78/025 mm2, respectively. A significant neuroprotective effect was observed in the pre-treated ischemic group (P < 0.001) in comparison to the ischemic group without pre-treatment. The average of c-Fos positive nuclei density in the CA1 region of hippocampus in the sham-operated rats, in ischemised rats without pre-treatment and in ischemised rats with statin pre-treatment was 0.266 с 0.074/025 mm2, 28.2 с 2.053/025 mm2, 30.3 с 4.816/025 mm2, respectively. A highly significant difference in c-Fos positivity (P < 0.001) was found between the sham operated group and both ischemic groups (with and without pre-treatment). No significant difference in c-Fos positivity was observed between untreated ischemic and pre-treated ischemic groups (P > 0.05). These findings indicate that simvastatin provides protection against CA1 hypoxic neuronal injury, which is independent of c-fos activation. We can conclude that simvastatin neuroprotection may be mediated by multiple mechanisms as can be expected based on its pleiotropic effects